Trade Summary

3 days ago, De Verneuil Vanina, serving as EVP, GC, Corp Sec at Vir Biotechnology, Inc. (VIR), sold 16,817 shares at $9.77 per share, for a total transaction value of $164,247.00. Following this transaction, De Verneuil Vanina now holds 112,982 shares of VIR.

This sale represents a 13.00% decrease in De Verneuil Vanina's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Vir Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.